A company based in Louisville, Kentucky, known as RAAPID Inc., and supported by Microsoft M12, has revealed advancements in its AI-driven risk adjustment solutions. The company announced an upgrade to its retrospective risk adjustment platform, now utilizing the Novel Clinical AI engine for Automated Retrospective Reviews. This innovative platform boasts a remarkable out-of-the-box accuracy of over 92%, which can increase to more than 98% with fina. This enhancement aims to cater to the increasing requirements of value-based care in the healthcare sector.